verapamil has been researched along with fosbretabulin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alami, M; Apcher, S; Benchekroun, M; Bernadat, G; Bignon, J; Borgel, D; Brion, JD; Darrigrand, R; Dubois, J; Hamze, A; Leblais, V; Lenoir, C; Leroux, FR; Levaique, H; Manoury, B; Naret, T; Pruvost, A; Saller, F; Schmitt, E | 1 |
Ai, W; Bao, N; Chen, H; Li, S; Li, W; Wang, S | 1 |
2 other study(ies) available for verapamil and fosbretabulin
Article | Year |
---|---|
A fluorine scan of a tubulin polymerization inhibitor isocombretastatin A-4: Design, synthesis, molecular modelling, and biological evaluation.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Fluorine; Humans; Models, Molecular; Molecular Structure; Polymerization; Stilbenes; Structure-Activity Relationship; Tubulin | 2018 |
The inhibitory effect of kokusaginine on the growth of human breast cancer cells and MDR-resistant cells is mediated by the inhibition of tubulin assembly.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dictamnus; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Furans; Humans; MCF-7 Cells; Molecular Structure; Quinolines; Structure-Activity Relationship; Tubulin | 2018 |